Ustredni Vojenska Nemocnice Vojenska Fakultni Nemocnice Praha

The medical center is at the forefront of research in metabolic dysfunction-associated steatohepatitis (NASH), focusing on innovative therapeutic approaches to manage and reduce the progression of this condition. The center's research aims to evaluate the histological grade and stage of NASH in patients undergoing specific therapies.

• Histological evaluation of NASH
• Therapeutic interventions for NASH

Through its research, the center contributes to the understanding of NASH and the development of effective treatment strategies.

Specializing in liver cirrhosis with features of portal hypertension, the center conducts advanced studies to assess the impact of combination therapies on hemodynamic parameters. This research is pivotal in improving patient outcomes and managing complications associated with liver cirrhosis.

• Combination therapy evaluation
• Portal hypertension management

The center's work in this area is instrumental in refining treatment protocols and enhancing the quality of life for patients with liver cirrhosis.

Focusing on neurosurgery, the center explores the effects of goal-directed fluid management on postoperative outcomes. Utilizing non-invasive technologies, the research aims to minimize complications and improve recovery in patients undergoing neurosurgical procedures.

• Goal-directed fluid management
• Postoperative complication reduction

This research enhances surgical protocols and patient care in neurosurgical settings.

The center is engaged in cutting-edge research in ocular oncology, particularly focusing on the treatment of primary indeterminate lesions and small choroidal melanoma. The studies aim to evaluate the efficacy and safety of novel therapeutic agents compared to standard controls.

• Choroidal melanoma treatment
• Safety and efficacy assessments

Through its research, the center is advancing the field of ocular oncology and offering new hope for patients with these conditions.

In the realm of heart failure, the center investigates the impact of innovative treatments on health-related quality of life. The research focuses on comparing new therapeutic agents with placebos to determine their effectiveness in improving patient well-being.

• Quality of life improvements
• Heart failure management

The center's contributions are vital in enhancing therapeutic approaches and patient experiences in heart failure management.